MicroRNA 548h-2 (MIR548H2)

MicroRNA 548h-2 (MIR548H2) is a short (20-24 nucleotide) non-coding RNA from the miRNA family, predicted to regulate gene expression post-transcriptionally by base-pairing with target mRNAs, leading to translation inhibition or mRNA degradation. Like other microRNAs, it is processed from a primary transcript by Drosha and Dicer ribonucleases and incorporated into the RNA-induced silencing complex (RISC)[1]. The broader miR-548 family has been linked to epigenetic signaling and cellular behavior in cancer, although specific biological and therapeutic roles for MIR548H2 remain poorly characterized[2]. There are no known drugs directly targeting MIR548H2, nor established biomarker or safety data[1]. Key details: - Not a canonical drug target (such as a receptor, enzyme, or transporter), but a regulatory RNA molecule[1]. - Aliases are variants of the abbreviation and nomenclature, reflecting HGNC, Ensembl, and miRBase registry[1]. - Molecular function is similar to other microRNAs: guides RISC to target mRNAs for repression. - Potential disease role is implicated via miR-548 family in cancer settings, particularly in cellular migration and signaling[2]. No evidence for other diseases or established biomarker/therapeutic use specific to MIR548H2[1][2]. - No evidence of drugs, mechanisms of action, or safety data specific to this miRNA[1][2].

Other names

hsa-mir-548h-2MIR548H-2MIRN548H2MIR548H2